UBS AM
DVAX

UBS AM’s Dynavax Technologies DVAX Stock Holding History

UBS AM’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-268,352
Closed -$4.13M – 3828
2025
Q4 		$4.13M Sell
268,352
-18,833
-7% -$207K ﹤0.01% 1563
2025
Q3 		$2.85M Sell
287,185
-205,540
-42% -$2.14M ﹤0.01% 1612
2025
Q2 		$4.89M Buy
492,725
+42,636
+9% +$449K ﹤0.01% 1716
2025
Q1 		$5.84M Buy
450,089
+29,764
+7% +$394K ﹤0.01% 1493
2024
Q4 		$5.37M Buy
420,325
+113,872
+37% +$1.38M ﹤0.01% 1569
2024
Q3 		$3.41M Sell
306,453
-240
-0.1% -$2.65K ﹤0.01% 1767
2024
Q2 		$3.44M Buy
306,693
+141,261
+85% +$1.64M ﹤0.01% 1699
2024
Q1 		$2.05M Hold
165,432
– – ﹤0.01% 1682
2023
Q4 		$2.31M Buy
165,432
+4,150
+3% +$57.6K ﹤0.01% 1621
2023
Q3 		$2.38M Buy
161,282
+29,714
+23% +$418K ﹤0.01% 1533
2023
Q2 		$1.29M Hold
131,568
– – ﹤0.01% 1884
2023
Q1 		$1.29M Buy
131,568
+15,216
+13% +$162K ﹤0.01% 1884
2022
Q4 		$1.24M Hold
116,352
– – ﹤0.01% 1748
2022
Q3 		$1.21M Sell
116,352
-1,204
-1% -$15.7K ﹤0.01% 1857
2022
Q2 		$1.48M Sell
117,556
-1,003
-0.8% -$10.7K ﹤0.01% 1758
2022
Q1 		$1.29M Hold
118,559
– – ﹤0.01% 2012
2021
Q4 		$1.67M Buy
118,559
+1,298
+1% +$21.4K ﹤0.01% 1956
2021
Q3 		$2.25M Sell
117,261
-19,619
-14% -$261K ﹤0.01% 1782
2021
Q2 		$1.35M Buy
136,880
+18,155
+15% +$165K ﹤0.01% 2038
2021
Q1 		$1.17M Sell
118,725
-189
-0.2% -$1.56K ﹤0.01% 2015
2020
Q4 		$529K Buy
118,914
+40,458
+52% +$183K ﹤0.01% 2282
2020
Q3 		$339K Sell
78,456
-1,571,844
-95% -$11.2M ﹤0.01% 2280
2020
Q2 		$14.6M Buy
1,650,300
+4,194
+0.3% +$21.2K 0.01% 825
2020
Q1 		$5.81M Sell
1,646,106
-95,000
-5% -$440K ﹤0.01% 1002
2019
Q4 		$9.96M Sell
1,741,106
-6,174
-0.4% -$33K 0.01% 947
2019
Q3 		$6.25M Buy
1,747,280
+5,373
+0.3% +$20.8K ﹤0.01% 1121
2019
Q2 		$6.95M Buy
1,741,907
+884,854
+103% +$5.13M 0.01% 1080
2019
Q1 		$6.27M Buy
857,053
+9,806
+1% +$95.9K ﹤0.01% 1073
2018
Q4 		$7.75M Buy
847,247
+294,912
+53% +$3.26M 0.01% 942
2018
Q3 		$6.85M Sell
552,335
-35,135
-6% -$475K 0.01% 1043
2018
Q2 		$8.96M Sell
587,470
-3,275
-0.6% -$56.6K 0.01% 974
2018
Q1 		$11.7M Buy
590,745
+565,885
+2,276% +$9.77M 0.01% 896
2017
Q4 		$465K Sell
24,860
-498,635
-95% -$10M ﹤0.01% 2005
2017
Q3 		$11.3M Sell
523,495
-252,432
-33% -$3.99M 0.01% 873
2017
Q2 		$7.49M Sell
775,927
-22,702
-3% -$147K 0.01% 951
2017
Q1 		$4.75M Sell
798,629
-2,986
-0.4% -$14.4K ﹤0.01% 1026
2016
Q4 		$3.17M Sell
801,615
-7,088
-0.9% -$51.9K ﹤0.01% 1110
2016
Q3 		$8.48M Buy
808,703
+270,280
+50% +$3.88M 0.01% 916
2016
Q2 		$7.85M Sell
538,423
-20,541
-4% -$351K 0.01% 923
2016
Q1 		$10.8M Buy
558,964
+542,627
+3,321% +$11M 0.01% 832
2015
Q4 		$395K Buy
16,337
+1,200
+8% +$30.1K ﹤0.01% 2183
2015
Q3 		$371K Buy
15,137
+6,088
+67% +$172K ﹤0.01% 2167
2015
Q2 		$212K Buy
+9,049
New +$197K ﹤0.01% 2561
2014
Q4 		– Sell
-7,350
Closed -$105K – 2620
2014
Q3 		$105K Hold
7,350
– – ﹤0.01% 2507
2014
Q2 		$118K Hold
7,350
– – ﹤0.01% 2513
2014
Q1 		$132K Hold
7,350
– – ﹤0.01% 2517
2013
Q4 		$144K Buy
7,350
+1,570
+27% +$23K ﹤0.01% 2458
2013
Q3 		$69K Sell
5,780
-161,839
-97% -$2.04M ﹤0.01% 2484
2013
Q2 		$1.84M Buy
+167,619
New +$3.53M ﹤0.01% 1246

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS AM's DVAX Position: Q1 2026 in Review

UBS AM sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 268,352 shares — an estimated $4.13M sold.

UBS AM first reported a position in DVAX in Q2 2013 and held it in 49 quarters. The position peaked at $14.6M in Q2 2020. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • UBS AM reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • UBS AM sold 268,352 Dynavax Technologies shares in Q1 2026, an estimated $4.13M.
  • UBS AM first reported a position in Dynavax Technologies in Q2 2013 and held it in 49 quarters.
  • UBS AM's Dynavax Technologies position peaked at $14.6M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.